Literature DB >> 11528260

Safety of ozonated solution as an antiseptic of the ocular surface prior to ophthalmic surgery.

K Kashiwagi1, K Saito, Y D Wang, H Takahashi, K Ishijima, S Tsukahara.   

Abstract

PURPOSE: To evaluate the safety of an ozonated solution as an antiseptic of the ocular surface prior to ophthalmic surgery.
METHODS: In experiment 1, a primary culture of rabbit corneal epithelium was established. Then, 0, 4 and 10 ppm ozonated solution and 1.25% povidone-iodine, respectively, were applied to confluent cells on collagen-coated filter inserts (Millicell-CM) for 10 min followed by replacement with fresh medium. The transepithelial electrical resistance (TER), which is a good indicator of cell barrier function, was sequentially measured for 30 min. In experiment 2, adult pigmented rabbit eyes were washed with 20 ml of 4 ppm ozonated solution, 1.25% povidone-iodine solution or saline. Slitlamp examinations were performed before and after washing.
RESULTS: In experiment 1, 4 ppm ozonated solution did not change the TER as compared with the control. 10 ppm ozonated solution and 1.25% povidone-iodine similarly reduced the TER values significantly as compared with those of the control and 4 ppm ozonated solution. In experiment 2, 4 ppm ozonated solution and saline showed mild superficial punctate keratitis (SPK) in 8.3% of eyes. However, 1.25% povidone-iodine resulted in mild SPK in 17% of eyes and moderate SPK in 25% of eyes. The prevalence of SPK between two groups was significantly different (p = 0.03).
CONCLUSION: Ozonated solution may be safe and a useful antiseptic of the ocular surface prior to ophthalmic surgery. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11528260     DOI: 10.1159/000050884

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  5 in total

1.  Morphological observations of rat corneal endothelial cells after exposure to ozonated solution.

Authors:  Hisaharu Suzuki; Shigeru Sato; Nao Murano; Hironori Matsui; Hideaki Oharazawa; Hiroshi Takahashi
Journal:  Jpn J Ophthalmol       Date:  2009-03-31       Impact factor: 2.447

Review 2.  Ozone therapy: a potential therapeutic adjunct for improving female reproductive health.

Authors:  Zaher Merhi; Bhavika Garg; Rajean Moseley-LaRue; Amber Ray Moseley; André Hugo Smith; John Zhang
Journal:  Med Gas Res       Date:  2019 Apr-Jun

Review 3.  Liposomal Ozonated Oil in Ocular Infections: A Review of Preclinical and Clinical Studies, Focusing on Its Antiseptic and Regenerative Properties.

Authors:  Juan J Pérez-Santonja; José Luis Güell; Oscar Gris; Xose Manuel Vázquez Dorrego; Esther Pellicer; Jose Manuel Benítez-Del-Castillo
Journal:  Clin Ophthalmol       Date:  2022-06-14

4.  The role of ozonized oil and a combination of tobramycin/dexamethasone eye drops in the treatment of viral conjunctivitis: a randomized clinical trial.

Authors:  C Cagini; M Mariniello; M Messina; A Muzi; C Balducci; A Moretti; L Levorato; A Mencacci
Journal:  Int Ophthalmol       Date:  2020-07-22       Impact factor: 2.031

5.  Antimycotic Activity of Ozonized Oil in Liposome Eye Drops against Candida spp.

Authors:  Giuseppe Celenza; Roberto Iorio; Salvatore Cracchiolo; Sabrina Petricca; Ciro Costagliola; Benedetta Cinque; Bernardetta Segatore; Gianfranco Amicosante; Pierangelo Bellio
Journal:  Transl Vis Sci Technol       Date:  2020-07-02       Impact factor: 3.283

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.